...DVT. Previous estimates are that 33 percent of patients with recurrent symptoms have acute thrombus. Diatide Inc....

...sites. One false negative and one false positive result was generated by the imaging agent. Diatide Inc....

...isotopes (samarium, strontium, and rhenium). Pain relief was comparable to that with the other agents. Diatide Inc....

...Data were presented at the meeting of the Radiological Society of North America in Chicago. Diatide Inc....

...Data were presented at the meeting of the Radiological Society of North America in Chicago. Diatide Inc....

...public and subsequently sold it to pharma. The new CEO, Richard Dean, founded imaging company Diatide...
...1996 at a post-money valuation of $87 million. Three years later, Schering (FSE:SCH; SHR) bought Diatide...

...consultant, Hawthorne was brought in to help get lifeboat financing and find a buyer for Diatide Inc....

...Center; and Patricia McDaniels as head of intellectual property management, formerly a patent attorney with Diatide Inc. WIR...

...Bioscience $492.0 Baxter North American Vaccine $390.0 Becton Dickinson Clontech $200.0 Biovail Fuisz $154.0 Schering Diatide...

...DITI for $9.50 per share in cash, or about $130 million (see BioCentury, Sept. 27). Diatide Inc....